FDA Approval of Palbociclib in Combination with Fulvestrant...

  • Main
  • 2016 / 07
  • FDA Approval of Palbociclib in Combination with Fulvestrant...
Clinical Cancer Research 2016 / 07

FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Walker, A. J., Wedam, S., Amiri-Kordestani, L., Bloomquist, E., Tang, S., Sridhara, R., Chen, W., Palmby, T. R., Fourie Zirkelbach, J., Fu, W., Liu, Q., Tilley, A., Kim, G., Kluetz, P. G., McKee, A. E
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-0493
Date:
July, 2016
File:
PDF, 162 KB
english, 2016
Conversion to is in progress
Conversion to is failed